The Jackson Laboratory, with the Broad Institute and Partners, Selected for ARPA-H THRIVE Award to Advance Gene Editing Platform for Pediatric Epilepsies and Rare CNS Diseases
Pediatric Epilepsies & Rare CNS Gene Editing Platform (PERC) aims to accelerate the development of precision genetic medicines for severe childhood neurologic diseases with limited or no effective treatment options. BAR HARBOR, Maine, July 9, 2026 /PRNewswire/ -- The Jackson Laboratory...
Pediatric Epilepsies & Rare CNS Gene Editing Platform (PERC) aims to accelerate the development of precision genetic medicines for severe childhood neurologic diseases with limited or no effective treatment options. BAR HARBOR, Maine, July 9, 2026 /PRNewswire/ -- The Jackson Laboratory...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.